Charles River Laboratories Intntl, Inc., Wilmington, MA, United States
See 20 grants from Rose Hood
See 158 grants from Charles River Laboratories Intntl, Inc.
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
How should you pick the next fundable research topic?
Recently viewed grants:
Engineering disease-specific T cells for pemphigus therapy
The Collaborative Cross Project of Diabetes
microRNA-10a Regulation of Inflammatory Bowel Diseases
Mechanisms of TF11/1 Function and Regulation
Drug Influx/Efflux Studies
Recently added grants:
Structured illumination multispectral fluorescence lifetime microendoscopy to detect oral premalignancies
Application of Health Behavior Models to Predict Hearing Healthcare Outcomes
Lipid Metabolism in the Retina
Cone sensitivity to temporal changes in color and luminance and the development of myopia
Thioredoxin Interacting Protein (TXNIP) expression is critical in the development of early diabetic retinopathy
National Institute of Health (NIH)
Research and Development Contracts (N01)
Charles River Laboratories Intntl, Inc.
Be the first to comment on this grant
Share this grant: